Literature DB >> 22504926

Control of murine Ly6C(high) monocyte traffic and immunosuppressive activities by atypical chemokine receptor D6.

Benedetta Savino1, Marina G Castor, Nicoletta Caronni, Adelaida Sarukhan, Achille Anselmo, Chiara Buracchi, Federica Benvenuti, Vanessa Pinho, Mauro M Teixeira, Alberto Mantovani, Massimo Locati, Raffaella Bonecchi.   

Abstract

The atypical chemokine receptor D6 is a decoy and scavenger receptor for most inflammatory CC chemokines and prevents the development of exacerbated inflammatory reactions. Here we report that mice lacking D6 expression in the nonhematopoietic compartment have a selective increase in the number of Ly6C(high) monocytes in the circulation and in secondary lymphoid tissues. Under inflammatory conditions, Ly6C(high) monocytes accumulate in increased number in secondary lymphoid organs of D6(-/-) mice in a CCR2-dependent manner. Ly6C(high) monocytes derived from D6(-/-) mice have enhanced immunosuppressive activity, inhibit the development of adaptive immune responses, and partially protect mice from the development of GVHD. Thus, control of CCR2 ligands by D6 regulates the traffic of Ly6C(high) monocytes and controls their immunosuppressive potential.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504926     DOI: 10.1182/blood-2011-10-388082

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  ILC3 in Axial Spondyloarthritis: the Gut Angle.

Authors:  Daniele Mauro; Federica Macaluso; Serena Fasano; Riccardo Alessandro; Francesco Ciccia
Journal:  Curr Rheumatol Rep       Date:  2019-06-13       Impact factor: 4.592

2.  Atypical chemokine receptor 2: a brake against Kaposi's sarcoma aggressiveness.

Authors:  Raffaella Bonecchi; Benedetta Savino; Nicoletta Caronni; Giuseppe Celesti; Alberto Mantovani; Massimo Locati
Journal:  Oncoimmunology       Date:  2015-01-07       Impact factor: 8.110

3.  Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.

Authors:  Kenneth E Bernstein; Yosef Koronyo; Brenda C Salumbides; Julia Sheyn; Lindsey Pelissier; Dahabada H J Lopes; Kandarp H Shah; Ellen A Bernstein; Dieu-Trang Fuchs; Jeff J-Y Yu; Michael Pham; Keith L Black; Xiao Z Shen; Sebastien Fuchs; Maya Koronyo-Hamaoui
Journal:  J Clin Invest       Date:  2014-03       Impact factor: 14.808

Review 4.  The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?

Authors:  Arezoo Gowhari Shabgah; Farhad Jadidi-Niaragh; Hamed Mohammadi; Farnoosh Ebrahimzadeh; Maziar Oveisee; Abbas Jahanara; Jamshid Gholizadeh Navashenaq
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

Review 5.  Immune regulation by atypical chemokine receptors.

Authors:  Robert J B Nibbs; Gerard J Graham
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

6.  Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.

Authors:  Raffaella Bonecchi; Cecilia Garlanda; Alberto Mantovani; Federica Riva
Journal:  Cytokine       Date:  2016-08-04       Impact factor: 3.861

7.  Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytes.

Authors:  Laura B Ford; Vuk Cerovic; Simon W F Milling; Gerard J Graham; Chris A H Hansell; Robert J B Nibbs
Journal:  J Immunol       Date:  2014-06-02       Impact factor: 5.422

8.  Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice.

Authors:  Jingbo Pang; Davina H Rhodes; Maria Pini; Rand T Akasheh; Karla J Castellanos; Robert J Cabay; Dianne Cooper; Mauro Perretti; Giamila Fantuzzi
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

9.  Mast Cell-Dependent CD8+ T-cell Recruitment Mediates Immune Surveillance of Intestinal Tumors in ApcMin/+ Mice.

Authors:  Sobha R Bodduluri; Steven Mathis; Paramahamsa Maturu; Elangovan Krishnan; Shuchismita R Satpathy; Paula M Chilton; Thomas C Mitchell; Sergio Lira; Massimo Locati; Alberto Mantovani; Venkatakrishna R Jala; Bodduluri Haribabu
Journal:  Cancer Immunol Res       Date:  2018-01-30       Impact factor: 12.020

10.  Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE Mice.

Authors:  Shirong Zheng; Susan Coventry; Lu Cai; David W Powell; Venkatakrishna R Jala; Bodduluri Haribabu; Paul N Epstein
Journal:  J Diabetes Res       Date:  2015-12-20       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.